HUAXIA EYE HOSPITAL GROUP CO.,LTD. Huaxia Eye Hospital Group Co.,Ltd. Stock
Equities
301267
CNE100005WL5
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.54 CNY | -1.67% |
|
+1.61% | -17.30% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 4.64B 643M | Sales 2025 * | 6.32B 875M | Capitalization | 22.53B 3.12B |
|---|---|---|---|---|---|
| Net income 2024 * | 788M 109M | Net income 2025 * | 1.1B 152M | EV / Sales 2024 * | 4.85 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.56 x |
| P/E ratio 2024 * |
28.7
x | P/E ratio 2025 * |
20.6
x | Employees | 7,613 |
| Yield 2024 * |
0.41% | Yield 2025 * |
-
| Free-Float | 11.63% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.15% | ||
| 1 week | +3.33% | ||
| Current month | +3.33% | ||
| 1 month | -0.04% | ||
| 3 months | -1.21% | ||
| 6 months | -34.59% | ||
| Current year | -15.89% |
1 week
26.36
27.27
1 month
23.5027.27
Current year
23.5032.17
1 year
23.5054.66
3 years
23.5063.25
5 years
23.5063.25
10 years
23.5063.25
| Managers | Title | Age | Since |
|---|---|---|---|
Qing Can Su
CEO | Chief Executive Officer | 55 | 04-07-31 |
Lu Yan Chen
DFI | Director of Finance/CFO | 46 | 15-12-31 |
Ni Ya Huang
CHM | Chairman | 44 | 05-05-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bei Zhao
BRD | Director/Board Member | 66 | 16-11-30 |
Yuan Lue Fu
BRD | Director/Board Member | 71 | 16-11-30 |
Xiao Dong Guo
BRD | Director/Board Member | 56 | 20-05-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 0 M€ | +3.53% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-07 | 26.54 | -1.67% | 3 860 383 |
| 24-05-07 | 26.99 | -0.15% | 2,709,626 |
| 24-05-06 | 27.03 | +3.48% | 5,717,195 |
| 24-04-30 | 26.12 | -0.27% | 3,765,820 |
End-of-day quote Shenzhen S.E., May 06, 2024
More quotes
Huaxia Eye Hospital Group Co Ltd is a China-based company mainly engaged in ophthalmic medical business. The Company's main business is to provide diagnosis and treatment services for ophthalmic diseases through ophthalmic medical institutions, including specialized medical services for cataract, refraction, fundus diseases, strabismus, amblyopia and pediatric ophthalmology, ocular surface diseases, glaucoma and others. The Company is also engaged in glasses and pharmacy retail business. The Company mainly conducts its business in the domestic market.
Calendar
2024-05-20
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
26.99
CNY
Average target price
50.02
CNY
Spread / Average Target
+85.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.89% | 3.12B | |
| -11.34% | 3B | |
| -23.23% | 331M | |
| +4.99% | 241M | |
| -47.17% | 183M | |
| -33.52% | 113M |
- Stock Market
- Equities
- 301267 Stock